Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · May 21, 2014

5-Year Survival After Acute Myocardial Infarction With Angiotensin-Converting Enzyme Inhibitors vs Angiotensin II Receptor Blockers

The American Journal of Cardiology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The American Journal of Cardiology
Comparison of 5-Year Survival After Acute Myocardial Infarction Using Angiotensin-Converting Enzyme Inhibitor Versus Angiotensin II Receptor Blocker
Am J Cardiol 2014 Apr 18;[EPub Ahead of Print], M Hara, Y Sakata, D Nakatani, S Suna, M Usami, S Matsumoto, T Sugitani, M Nishino, H Sato, T Kitamura, S Nanto, T Hamasaki, M Hori, I Komuro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading